FORM vs REGN · P/E 143, rev $763.6M vs P/E 14, rev $14.34B
FormFactor Inc (FORM) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
FormFactor Inc (FORM) is a semiconductor equipment & materials company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FORM revenue for 2024-12-28 was $763.6M. Net income was $69.6M. Revenue was up 15.2% from 2023-12-30 to 2024-12-28. FORM currently screens at market cap $9.71B and trailing P/E 143.2.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FORM currently screens at market cap $9.71B and trailing P/E 143.2. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FORM and REGN stock pages for the full models.
Not investment advice.